Efficacy and safety of vildagliptine and metformin in patients with newly diagnosed type 2 diabetes: results of the observational program «VIL-DA!»

Authors

Publication Details

Journal
Endocrinology News Opinions Training
Published
2025-01-01
DOI
https://doi.org/10.33029/2304-9529-2025-14-1-7-17
Citations
1
Primary Topic
Neurological Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.84
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and safety of vildagliptine and metformin in patients with newly diagnosed type 2 diabetes: results of the observational program «VIL-DA!»

Н. А. Петунина, Ametov As, Т. Л. Каронова, Н. С. Мартиросян
1 citations
Endocrinology News Opinions Training
Neurological Disorders and Treatments
0.84
article

Efficacy and safety of vildagliptine and metformin in patients with newly diagnosed type 2 diabetes: results of the observational program «VIL-DA!»

Н. А. Петунина, Ametov As, Т. Л. Каронова, Н. С. Мартиросян
article en
1 citations

Abstract

No abstract available for this paper.
Endocrinology News Opinions TrainingVol. 14(1)
Openalex Percentile: Top 25%
Neurological Disorders and Treatments
0.84
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Efficacy and safety of vildagliptine and metformin in patients with newly diagnosed type 2 diabetes: results of the observational program «VIL-DA!» — Н. А. Петунина, Ametov As, et al. · Endocrinology News Opinions Training (2025) | TGRS Research Map | TGRS